Thomas S. K. Wan

1.5k total citations
56 papers, 1.1k citations indexed

About

Thomas S. K. Wan is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Thomas S. K. Wan has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 24 papers in Hematology and 12 papers in Genetics. Recurrent topics in Thomas S. K. Wan's work include Acute Myeloid Leukemia Research (17 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Thomas S. K. Wan is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Thomas S. K. Wan collaborates with scholars based in Hong Kong, China and United States. Thomas S. K. Wan's co-authors include Edmond S.K., Sai‐Wah Tsao, Li Chong Chan, Alfred K. Lam, Edward G. Fey, Michael G. Muto, Jonathan A. Fletcher, Robert C. Knapp, Samuel C. Mok and Ross S. Berkowitz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Thomas S. K. Wan

52 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas S. K. Wan Hong Kong 19 630 276 226 194 163 56 1.1k
Ravindran Ankathil Malaysia 22 649 1.0× 251 0.9× 318 1.4× 225 1.2× 267 1.6× 99 1.3k
Joni Van der Meulen Belgium 17 570 0.9× 389 1.4× 155 0.7× 123 0.6× 90 0.6× 43 1.0k
Masayuki Shiseki Japan 21 960 1.5× 302 1.1× 439 1.9× 116 0.6× 161 1.0× 53 1.6k
Alessandra Tosolini United States 16 570 0.9× 136 0.5× 387 1.7× 338 1.7× 110 0.7× 28 1.2k
Maria Grazia di Iasio Italy 18 686 1.1× 205 0.7× 415 1.8× 127 0.7× 67 0.4× 28 1.1k
Hiroyoshi Hattori Japan 17 435 0.7× 109 0.4× 310 1.4× 104 0.5× 126 0.8× 39 989
Bellinda A. Bladergroen Netherlands 17 399 0.6× 156 0.6× 200 0.9× 111 0.6× 68 0.4× 19 1.0k
Xiulan Yang United States 14 442 0.7× 379 1.4× 260 1.2× 90 0.5× 79 0.5× 25 861
Lisa Haley United States 18 526 0.8× 186 0.7× 290 1.3× 84 0.4× 65 0.4× 39 1.1k

Countries citing papers authored by Thomas S. K. Wan

Since Specialization
Citations

This map shows the geographic impact of Thomas S. K. Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas S. K. Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas S. K. Wan more than expected).

Fields of papers citing papers by Thomas S. K. Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas S. K. Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas S. K. Wan. The network helps show where Thomas S. K. Wan may publish in the future.

Co-authorship network of co-authors of Thomas S. K. Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas S. K. Wan. A scholar is included among the top collaborators of Thomas S. K. Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas S. K. Wan. Thomas S. K. Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Au, Chun Hang, Amy Wing-Sze Leung, Henry C. M. Leung, et al.. (2025). A multi-modal molecular characterization of the Philadelphia translocation featuring long read sequencing. Gene. 950. 149370–149370.
2.
Au, Chun Hang, et al.. (2024). Clinical Evaluation of the BIOFIRE SPOTFIRE Respiratory Panel. Viruses. 16(4). 600–600. 3 indexed citations
3.
Au, Chun Hang, Chor Sang Chim, Raymond Liang, et al.. (2024). Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies. Scientific Reports. 14(1). 6400–6400. 10 indexed citations
4.
Chan, Hoi–Yun, Kam Tong Leung, Kathy Yuen Yee Chan, et al.. (2023). Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia. Communications Biology. 6(1). 356–356. 2 indexed citations
5.
Au, Chun Hang, et al.. (2023). The Seasonality of Respiratory Viruses in a Hong Kong Hospital, 2014–2023. Viruses. 15(9). 1820–1820. 14 indexed citations
6.
Wan, Thomas S. K., et al.. (2016). Chromosome Recognition. Methods in molecular biology. 1541. 67–74. 1 indexed citations
7.
Yang, John, Tae Sung Park, & Thomas S. K. Wan. (2016). Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia. Methods in molecular biology. 1541. 223–245. 24 indexed citations
8.
Lam, David, Wen Deng, Jaime Rodriguez‐Canales, et al.. (2015). Oncogenic mutation profiling in new lung cancer and mesothelioma cell lines. OncoTargets and Therapy. 8. 195–195. 4 indexed citations
9.
Wan, Thomas S. K., et al.. (2014). Epigenetic inactivation of DAPK1 , p14 ARF , mir-34a and -34b/c in acute promyelocytic leukaemia. Journal of Clinical Pathology. 67(7). 626–631. 18 indexed citations
10.
Wan, Thomas S. K.. (2014). Cancer Cytogenetics: Methodology Revisited. Annals of Laboratory Medicine. 34(6). 413–425. 35 indexed citations
11.
Chim, Chor Sang, Sze Fai Yip, Joycelyn Sim, et al.. (2012). Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD. Journal of Hematology & Oncology. 5(1). 28–28. 10 indexed citations
12.
Meyer, Claus, Eric Kowarz, Sze‐Fai Yip, et al.. (2011). A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemia. Cancer Genetics. 204(10). 557–562. 6 indexed citations
13.
Chim, Chor Sang, et al.. (2011). Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms. Journal of Translational Medicine. 9(1). 197–197. 37 indexed citations
14.
Au, Wing‐Yan, et al.. (2008). Unexpected glucose‐6‐phosphate dehydrogenase deficiency. British Journal of Haematology. 145(6). 680–680. 2 indexed citations
15.
Au, Wing Y., et al.. (2003). Pentasomy 8q in therapy-related myelodysplastic syndrome due to cyclophosphamide therapy for fibrosing alveolitis. Cancer Genetics and Cytogenetics. 141(1). 79–82. 6 indexed citations
16.
Hu, Ying, Alfred K. Lam, Simon Law, et al.. (2002). Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3. Cancer Genetics and Cytogenetics. 135(2). 120–127. 48 indexed citations
17.
Tang, Johnny, Thomas S. K. Wan, Nathalie Wong, et al.. (2001). Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genetics and Cytogenetics. 124(1). 36–41. 43 indexed citations
18.
Lam, Alfred K., Thomas S. K. Wan, Wei‐gang Fang, et al.. (2000). Establishment and Characterization of HKESC-1, a New Cancer Cell Line from Human Esophageal Squamous Cell Carcinoma. Cancer Genetics and Cytogenetics. 118(2). 112–120. 58 indexed citations
19.
Wan, Thomas S. K., L.C. Chan, Hys Ngan, & Sai‐Wah Tsao. (1997). tHigh frequency of telomeric associations in human ovarian surface epithelial cells transformed by human papilloma viral oncogenes. Cancer Genetics and Cytogenetics. 95(2). 166–172. 24 indexed citations
20.
Tsao, Sai‐Wah, Samuel C. Mok, Edward G. Fey, et al.. (1995). Characterization of Human Ovarian Surface Epithelial Cells Immortalized by Human Papilloma Viral Oncogenes (HPV-E6E7 ORFs). Experimental Cell Research. 218(2). 499–507. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ravindran Ankathil Breakdown of academic impact, for papers by Joni Van der Meulen Breakdown of academic impact, for papers by Masayuki Shiseki Breakdown of academic impact, for papers by Alessandra Tosolini Breakdown of academic impact, for papers by Maria Grazia di Iasio Breakdown of academic impact, for papers by Hiroyoshi Hattori Breakdown of academic impact, for papers by Bellinda A. Bladergroen Breakdown of academic impact, for papers by Xiulan Yang Breakdown of academic impact, for papers by Lisa Haley
Rankless by CCL
2026